Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Nucleic Acids Research|May 26, 2017
Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation eventsEmil L Kristoffersen, Asger Givskov, Line A Jørgensen, et al.
Oncogene|July 4, 2002
MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage siteDiana J Slater, Eva Hilgenfeld, Eric F Rappaport, et al.
Molecular Cancer Therapeutics|January 30, 2004
Biological characterization of MLN944: a potent DNA binding agentDarshan S Sappal, A Kathleen McClendon, James A Fleming, et al.
ACS Infectious Diseases|January 10, 2025
Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated LinkersMark J Mitton-Fry, Jason E Cummings, Yanran Lu, et al.
Genome Research|April 8, 2017
Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed lociXiang Yu, James W Davenport, Karen A Urtishak, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 9, 2023
Professional Identity Formation of Basic Science Medical Educators: A Qualitative Study of Identity Supports and ThreatsJoanna Veazey Brooks, Bonny L Dickinson, Kelly M Quesnelle, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Development of Novel Bacterial Topoisomerase Inhibitors Assisted by Computational ScreeningJoshua W Powell, Chelsea A Mann, Paul D Toth, et al.
Journal of Medicinal Chemistry|October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over βJose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
Oncogene|November 25, 2003
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingRyan J Whitmarsh, Charles Saginario, Ya Zhuo, et al.
ACS Infectious Diseases|December 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II TopoisomerasesChelsea A Mann, Stephanie A Halasohoris, Annette M Gray, et al.
Pageof 15